Immunarray vs Visby Medical

Immunarray vs Visby Medical, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunarray is on 39/100 and Visby Medical on 58/100.

Immunarray logo
ImmunarrayImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform.
Try Immunarray
Visby Medical logo
Visby MedicalVisby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.
Try Visby Medical

Where each one leads

Immunarray

Leads on none of the measures we hold for both companies.

Visby Medical

  • our overall score: 58/100 against 39/100
  • agent readiness: 60/100 against 28/100
  • domain rating: 52/100 against 18/100
  • funding raised: $331M against $10.0M

At a glance

MeasureImmunarrayVisby Medical
What it isImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform.Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.
CategoryHealthcare, Blood, Diagnostics, ImmunologyHealthcare, MedTech, HealthTech, Diagnostics
Sells toBusiness modelB2BB2B
OfferingSoftwareHardware
Founded20062012
HeadquartersRichmond, United StatesSan Jose, United States
StatusInactiveActive

Size, funding and growth

MeasureImmunarrayVisby Medical
EmployeesNot published179
Headcount growthLast 12 monthsNot published-6.5%
Total funding$10.0M$331M
Latest roundSeries ASeries E
ValuationNot published$1.0B
LinkedIn followersNot published15,208

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureImmunarrayVisby Medical
StartupHub scoreOur 0-100 rating39/10058/100
Traction35/10060/100
Team30/10030/100
Community13/100Not published
Search visibility5/10037/100
Quality45/10065/100
Agent readinessHow well an AI agent can read and act on the siteF (28/100)C (60/100)
Domain ratingLink authority, 0-10018/10052/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureImmunarrayVisby Medical
CDNNot detectedCloudflare
CMSNot detectedShopify
FrameworksNot detectedJquery, Bootstrap
AnalyticsNot detectedGoogle Tag Manager

What users say

MeasureImmunarrayVisby Medical
Reddit sentimentThreads we trackNot published6 positive, 0 negative across 6 threads
Visby Medical
The Visby Medical Women’s Sexual Health Test is a prescription-free test that has received approval from the FDA for an innovative at-home diagnostic solution. This test detects chlamydia, gonorrhea, and trichomoniasis and delivers results
r/EverythingScience

Immunarray vs Visby Medical: common questions

Which is better, Immunarray or Visby Medical?

On our 0-100 score Visby Medical rates higher (58/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Immunarray and Visby Medical compare on the numbers?

Visby Medical leads on our overall score (58/100 against 39/100), agent readiness (60/100 against 28/100), domain rating (52/100 against 18/100), funding raised ($331M against $10.0M).

What do real users say about Immunarray and Visby Medical?

Visby Medical: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/EverythingScience.

Read the full Immunarray review and pricing or the Visby Medical review and pricing. You can also browse other Immunarray alternatives we track.